Inhibition of UBE2N‐dependent CDK6 protein degradation by miR‐934 promotes human bladder cancer cell growth-Reference-Cited by-同舟云学术

Inhibition of UBE2N‐dependent CDK6 protein degradation by miR‐934 promotes human bladder cancer cell growth

Published:2019-08-02 Issue:11 Volume:33 Page:12112-12123
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Yan Huiying¹,Ren Shuwei¹,Lin Qi²,Yu Yuan¹,Chen Caiyi¹,Hua Xiaohui¹,Jin Honglei¹,Lu Yongyong²,Zhang Huxiang²,Xie Qipeng¹,Huang Chuanshu³,Huang Haishan¹

Affiliation:

1. Zhejiang Provincial Key Laboratory for Technology and Application of Model OrganismsKey Laboratory of Laboratory Medicine, Ministry of EducationSchool of Laboratory Medicine and Life SciencesWenzhou Medical UniversityWenzhouZhejiangChina

2. The First Affiliated Hospital of Wenzhou Medical UniversityWenzhouZhejiangChina

3. Department of Environmental MedicineNew York University School of MedicineNew YorkNew YorkUSA

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201900499RR

Reference49 articles.

1. Focus on bladder cancer

2. Targeting CDK4 and CDK6: From Discovery to Therapy

3. Elevated activity of cyclin‐dependent kinase ± in human squamous cell carcinoma lines;Timmermann S.;Cell Growth Differ.,1997

4. miR‐377 inhibited tumorous behaviors of non‐small cell lung cancer through directly targeting CDK6;Zhang J.;Eur. Rev. Med. Pharmacol. Sci.,2016

5. Cyclin-dependent kinase 6 associates with the androgen receptor and enhances its transcriptional activity in prostate cancer cells

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SelK promotes glioblastoma cell proliferation by inhibiting β-TrCP1 mediated ubiquitin-dependent degradation of CDK4;Journal of Experimental & Clinical Cancer Research;2024-08-19

2. The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy;Molecular Therapy: Oncology;2024-06

3. CRTAC1 enhances the chemosensitivity of non-small cell lung cancer to cisplatin by eliciting RyR-mediated calcium release and inhibiting Akt1 expression;Cell Death & Disease;2023-08-26

4. circRNF10 Regulates Tumorigenic Properties and Natural Killer Cell-Mediated Cytotoxicity against Breast Cancer through the miR-934/PTEN/PI3k-Akt Axis;Cancers;2022-11-28

5. TRIM14 inhibits OPTN-mediated autophagic degradation of KDM4D to epigenetically regulate inflammation;Proceedings of the National Academy of Sciences;2022-02-10